The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automated Molecular Diagnostics Testing System Market Research Report 2025
Synopsis
Global Automated Molecular Diagnostics Testing System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automated Molecular Diagnostics Testing System market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automated Molecular Diagnostics Testing System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Holding AG
Abbott Laboratories
Becton Dickenson & Company
Siemens Healthcare GmbH
Enigma Diagnostics Ltd
Qiagen
Bio-Rad Laboratories
Cepheid Inc.
PerkinElmer Inc.
AutoGenomics
ELITech Group
Segment by Type
PCR (Polymerase Chain Reaction)
FISH (Fluorescent In-situ Hybridization)
Spectral Karyotype Imaging
DNA Microarrays
Segment by Application
Pathology Laboratories
Hospitals
Research Centers
Academic Institutions
Commercial R&D Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Automated Molecular Diagnostics Testing System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Automated Molecular Diagnostics Testing System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automated Molecular Diagnostics Testing System market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automated Molecular Diagnostics Testing System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Holding AG
Abbott Laboratories
Becton Dickenson & Company
Siemens Healthcare GmbH
Enigma Diagnostics Ltd
Qiagen
Bio-Rad Laboratories
Cepheid Inc.
PerkinElmer Inc.
AutoGenomics
ELITech Group
Segment by Type
PCR (Polymerase Chain Reaction)
FISH (Fluorescent In-situ Hybridization)
Spectral Karyotype Imaging
DNA Microarrays
Segment by Application
Pathology Laboratories
Hospitals
Research Centers
Academic Institutions
Commercial R&D Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Automated Molecular Diagnostics Testing System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Automated Molecular Diagnostics Testing System Market Overview
1.1 Product Overview and Scope of Automated Molecular Diagnostics Testing System
1.2 Automated Molecular Diagnostics Testing System Segment by Type
1.2.1 Global Automated Molecular Diagnostics Testing System Market Value Comparison by Type (2023-2029)
1.2.2 PCR (Polymerase Chain Reaction)
1.2.3 FISH (Fluorescent In-situ Hybridization)
1.2.4 Spectral Karyotype Imaging
1.2.5 DNA Microarrays
1.3 Automated Molecular Diagnostics Testing System Segment by Application
1.3.1 Global Automated Molecular Diagnostics Testing System Market Value by Application: (2023-2029)
1.3.2 Pathology Laboratories
1.3.3 Hospitals
1.3.4 Research Centers
1.3.5 Academic Institutions
1.3.6 Commercial R&D Centers
1.4 Global Automated Molecular Diagnostics Testing System Market Size Estimates and Forecasts
1.4.1 Global Automated Molecular Diagnostics Testing System Revenue 2018-2029
1.4.2 Global Automated Molecular Diagnostics Testing System Sales 2018-2029
1.4.3 Global Automated Molecular Diagnostics Testing System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Automated Molecular Diagnostics Testing System Market Competition by Manufacturers
2.1 Global Automated Molecular Diagnostics Testing System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Automated Molecular Diagnostics Testing System Average Price by Manufacturers (2018-2023)
2.4 Global Automated Molecular Diagnostics Testing System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Automated Molecular Diagnostics Testing System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Molecular Diagnostics Testing System, Product Type & Application
2.7 Automated Molecular Diagnostics Testing System Market Competitive Situation and Trends
2.7.1 Automated Molecular Diagnostics Testing System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Molecular Diagnostics Testing System Players Market Share by Revenue
2.7.3 Global Automated Molecular Diagnostics Testing System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Molecular Diagnostics Testing System Retrospective Market Scenario by Region
3.1 Global Automated Molecular Diagnostics Testing System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Automated Molecular Diagnostics Testing System Global Automated Molecular Diagnostics Testing System Sales by Region: 2018-2029
3.2.1 Global Automated Molecular Diagnostics Testing System Sales by Region: 2018-2023
3.2.2 Global Automated Molecular Diagnostics Testing System Sales by Region: 2024-2029
3.3 Global Automated Molecular Diagnostics Testing System Global Automated Molecular Diagnostics Testing System Revenue by Region: 2018-2029
3.3.1 Global Automated Molecular Diagnostics Testing System Revenue by Region: 2018-2023
3.3.2 Global Automated Molecular Diagnostics Testing System Revenue by Region: 2024-2029
3.4 North America Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.4.1 North America Automated Molecular Diagnostics Testing System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Automated Molecular Diagnostics Testing System Sales by Country (2018-2029)
3.4.3 North America Automated Molecular Diagnostics Testing System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.5.1 Europe Automated Molecular Diagnostics Testing System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Automated Molecular Diagnostics Testing System Sales by Country (2018-2029)
3.5.3 Europe Automated Molecular Diagnostics Testing System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Molecular Diagnostics Testing System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Automated Molecular Diagnostics Testing System Sales by Country (2018-2029)
3.6.3 Asia Pacific Automated Molecular Diagnostics Testing System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.7.1 Latin America Automated Molecular Diagnostics Testing System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Automated Molecular Diagnostics Testing System Sales by Country (2018-2029)
3.7.3 Latin America Automated Molecular Diagnostics Testing System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Molecular Diagnostics Testing System Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Molecular Diagnostics Testing System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Automated Molecular Diagnostics Testing System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Automated Molecular Diagnostics Testing System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Molecular Diagnostics Testing System Sales by Type (2018-2029)
4.1.1 Global Automated Molecular Diagnostics Testing System Sales by Type (2018-2023)
4.1.2 Global Automated Molecular Diagnostics Testing System Sales by Type (2024-2029)
4.1.3 Global Automated Molecular Diagnostics Testing System Sales Market Share by Type (2018-2029)
4.2 Global Automated Molecular Diagnostics Testing System Revenue by Type (2018-2029)
4.2.1 Global Automated Molecular Diagnostics Testing System Revenue by Type (2018-2023)
4.2.2 Global Automated Molecular Diagnostics Testing System Revenue by Type (2024-2029)
4.2.3 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Type (2018-2029)
4.3 Global Automated Molecular Diagnostics Testing System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Automated Molecular Diagnostics Testing System Sales by Application (2018-2029)
5.1.1 Global Automated Molecular Diagnostics Testing System Sales by Application (2018-2023)
5.1.2 Global Automated Molecular Diagnostics Testing System Sales by Application (2024-2029)
5.1.3 Global Automated Molecular Diagnostics Testing System Sales Market Share by Application (2018-2029)
5.2 Global Automated Molecular Diagnostics Testing System Revenue by Application (2018-2029)
5.2.1 Global Automated Molecular Diagnostics Testing System Revenue by Application (2018-2023)
5.2.2 Global Automated Molecular Diagnostics Testing System Revenue by Application (2024-2029)
5.2.3 Global Automated Molecular Diagnostics Testing System Revenue Market Share by Application (2018-2029)
5.3 Global Automated Molecular Diagnostics Testing System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche Holding AG
6.1.1 Roche Holding AG Corporation Information
6.1.2 Roche Holding AG Description and Business Overview
6.1.3 Roche Holding AG Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Holding AG Automated Molecular Diagnostics Testing System Product Portfolio
6.1.5 Roche Holding AG Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories Automated Molecular Diagnostics Testing System Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Becton Dickenson & Company
6.3.1 Becton Dickenson & Company Corporation Information
6.3.2 Becton Dickenson & Company Description and Business Overview
6.3.3 Becton Dickenson & Company Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Becton Dickenson & Company Automated Molecular Diagnostics Testing System Product Portfolio
6.3.5 Becton Dickenson & Company Recent Developments/Updates
6.4 Siemens Healthcare GmbH
6.4.1 Siemens Healthcare GmbH Corporation Information
6.4.2 Siemens Healthcare GmbH Description and Business Overview
6.4.3 Siemens Healthcare GmbH Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siemens Healthcare GmbH Automated Molecular Diagnostics Testing System Product Portfolio
6.4.5 Siemens Healthcare GmbH Recent Developments/Updates
6.5 Enigma Diagnostics Ltd
6.5.1 Enigma Diagnostics Ltd Corporation Information
6.5.2 Enigma Diagnostics Ltd Description and Business Overview
6.5.3 Enigma Diagnostics Ltd Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Enigma Diagnostics Ltd Automated Molecular Diagnostics Testing System Product Portfolio
6.5.5 Enigma Diagnostics Ltd Recent Developments/Updates
6.6 Qiagen
6.6.1 Qiagen Corporation Information
6.6.2 Qiagen Description and Business Overview
6.6.3 Qiagen Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Qiagen Automated Molecular Diagnostics Testing System Product Portfolio
6.6.5 Qiagen Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.6.1 Bio-Rad Laboratories Corporation Information
6.6.2 Bio-Rad Laboratories Description and Business Overview
6.6.3 Bio-Rad Laboratories Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Rad Laboratories Automated Molecular Diagnostics Testing System Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 Cepheid Inc.
6.8.1 Cepheid Inc. Corporation Information
6.8.2 Cepheid Inc. Description and Business Overview
6.8.3 Cepheid Inc. Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cepheid Inc. Automated Molecular Diagnostics Testing System Product Portfolio
6.8.5 Cepheid Inc. Recent Developments/Updates
6.9 PerkinElmer Inc.
6.9.1 PerkinElmer Inc. Corporation Information
6.9.2 PerkinElmer Inc. Description and Business Overview
6.9.3 PerkinElmer Inc. Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 PerkinElmer Inc. Automated Molecular Diagnostics Testing System Product Portfolio
6.9.5 PerkinElmer Inc. Recent Developments/Updates
6.10 AutoGenomics
6.10.1 AutoGenomics Corporation Information
6.10.2 AutoGenomics Description and Business Overview
6.10.3 AutoGenomics Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AutoGenomics Automated Molecular Diagnostics Testing System Product Portfolio
6.10.5 AutoGenomics Recent Developments/Updates
6.11 ELITech Group
6.11.1 ELITech Group Corporation Information
6.11.2 ELITech Group Automated Molecular Diagnostics Testing System Description and Business Overview
6.11.3 ELITech Group Automated Molecular Diagnostics Testing System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ELITech Group Automated Molecular Diagnostics Testing System Product Portfolio
6.11.5 ELITech Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Molecular Diagnostics Testing System Industry Chain Analysis
7.2 Automated Molecular Diagnostics Testing System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Molecular Diagnostics Testing System Production Mode & Process
7.4 Automated Molecular Diagnostics Testing System Sales and Marketing
7.4.1 Automated Molecular Diagnostics Testing System Sales Channels
7.4.2 Automated Molecular Diagnostics Testing System Distributors
7.5 Automated Molecular Diagnostics Testing System Customers
8 Automated Molecular Diagnostics Testing System Market Dynamics
8.1 Automated Molecular Diagnostics Testing System Industry Trends
8.2 Automated Molecular Diagnostics Testing System Market Drivers
8.3 Automated Molecular Diagnostics Testing System Market Challenges
8.4 Automated Molecular Diagnostics Testing System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
